Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason K Perry

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Nature Structural & Molecular Biology|March 9, 2022
Ensemble cryo-EM reveals conformational states of the nsp13 helicase in the SARS-CoV-2 helicase replication-transcription complexJames Chen, Qi Wang, Brandon Malone, et al.
Viruses|February 27, 2026
Antiviral Activity of Remdesivir and Obeldesivir Against SARS-CoV-2 Omicron Subvariants That Were Circulating from September 2023 Through June 2025Lauren Rodriguez, Jiani Li, Dong Han, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2022
<i>In Vitro</i> Selection of Remdesivir-Resistant SARS-CoV-2 Demonstrates High Barrier to ResistanceLiva Checkmahomed, Julie Carbonneau, Venice Du Pont, et al.
Antiviral Research|December 31, 2025
SARS-CoV-2 Resistance Analyses From the Phase 3 OAKTREE Study of Obeldesivir in Low-Risk Nonhospitalized Participants With COVID-19Lauren Rodriguez, Yu Hu, Jiani Li, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2011
Structural and binding analysis of pyrimidinol carboxylic acid and N-hydroxy quinazolinedione HIV-1 RNase H inhibitorsEric B Lansdon, Qi Liu, Stephanie A Leavitt, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2015
Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C VirusJoy Y Feng, Yili Xu, Ona Barauskas, et al.
Antiviral Research|January 21, 2026
SARS-CoV-2 Resistance Analyses From the Phase 3 BIRCH Study of Obeldesivir in High-Risk Nonhospitalized Participants With COVID-19Charlotte Hedskog, Lauren Rodriguez, Yu Hu, et al.
Science (New York, N.Y.)|February 14, 2015
Viral replication. Structural basis for RNA replication by the hepatitis C virus polymeraseTodd C Appleby, Jason K Perry, Eisuke Murakami, et al.
Viruses|February 26, 2025
Remdesivir and Obeldesivir Retain Potent Antiviral Activity Against SARS-CoV-2 Omicron VariantsLauren Rodriguez, J Lizbeth Reyes Zamora, Dong Han, et al.
Science Translational Medicine|January 7, 2026
Lenacapavir treatment-emergent HIV-1 capsid resistance mutations are frequently associated with replication defectsNina Pennetzdorfer, Vidula Naik, Sally Demirdjian, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Nature Structural & Molecular Biology|March 9, 2022
Ensemble cryo-EM reveals conformational states of the nsp13 helicase in the SARS-CoV-2 helicase replication-transcription complexJames Chen, Qi Wang, Brandon Malone, et al.
Viruses|February 27, 2026
Antiviral Activity of Remdesivir and Obeldesivir Against SARS-CoV-2 Omicron Subvariants That Were Circulating from September 2023 Through June 2025Lauren Rodriguez, Jiani Li, Dong Han, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2022
<i>In Vitro</i> Selection of Remdesivir-Resistant SARS-CoV-2 Demonstrates High Barrier to ResistanceLiva Checkmahomed, Julie Carbonneau, Venice Du Pont, et al.
Antiviral Research|December 31, 2025
SARS-CoV-2 Resistance Analyses From the Phase 3 OAKTREE Study of Obeldesivir in Low-Risk Nonhospitalized Participants With COVID-19Lauren Rodriguez, Yu Hu, Jiani Li, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2011
Structural and binding analysis of pyrimidinol carboxylic acid and N-hydroxy quinazolinedione HIV-1 RNase H inhibitorsEric B Lansdon, Qi Liu, Stephanie A Leavitt, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2015
Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C VirusJoy Y Feng, Yili Xu, Ona Barauskas, et al.
Antiviral Research|January 21, 2026
SARS-CoV-2 Resistance Analyses From the Phase 3 BIRCH Study of Obeldesivir in High-Risk Nonhospitalized Participants With COVID-19Charlotte Hedskog, Lauren Rodriguez, Yu Hu, et al.
Science (New York, N.Y.)|February 14, 2015
Viral replication. Structural basis for RNA replication by the hepatitis C virus polymeraseTodd C Appleby, Jason K Perry, Eisuke Murakami, et al.
Viruses|February 26, 2025
Remdesivir and Obeldesivir Retain Potent Antiviral Activity Against SARS-CoV-2 Omicron VariantsLauren Rodriguez, J Lizbeth Reyes Zamora, Dong Han, et al.
Science Translational Medicine|January 7, 2026
Lenacapavir treatment-emergent HIV-1 capsid resistance mutations are frequently associated with replication defectsNina Pennetzdorfer, Vidula Naik, Sally Demirdjian, et al.
Pageof 4